References
- Barrett-Connor E., Bush T. L. Estrogen and coronary heart disease in women. JAMA 1991; 265: 1861–7
- Colditz G. A., Willett W. C., Stampfer M. J., Rosner B., Speizer F. E., Hennekens C. H. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316: 1105–10
- Lobo R. A. Cardiovascular implications of oestrogen replacement therapy. Obstet Gynecol 1990; 75: 18S–25S
- Magness R. R., Rosenfeld C. R. Local and systemic oestradiol-17 beta: effects on uterine and systemic vasodilatation. Am J Physiol 1989; E536–42
- Sarrel P. M. Ovarian hormones and the circulation. Maturitas 1990; 590: 287–98
- Jespersen C. M., Arming K., Hagen C., Hilden T., Neilsen F., Damkjaer Nielsen M. D., Giese J. Effects of natural oestrogen therapy on blood pressure and renin-angiotensin system in normotensive and hypertensive menopausal women. J Hypertens 1983; 1: 361–4
- Luotola H., Pyörälä T., Lähteenmäki P., Toivanen J. Haemodynamic and hormonal effects of short-term oestradiol treatment in postmenopausal women. Maturitas 1979; 1: 287–94
- Ueda S., Fortune V., Bull B. S., Valenzuela G. J., Longo L. D. Oestrogen effects on plasma volume, arterial blood pressure, interstitial space, plasma proteins, and blood viscosity in sheep. Am J Obstet Gynecol 1986; 155: 195–201
- Bee J., Humerfelt S., Wedervang F. The blood pressure in a population. Blood pressure readings and height and weight determinations in the adult population of the city of Bergen. Acta Med Scand (Suppl 321) 1957; 157: 1–336
- Tollan A., Hoist N., Forsdahl F., Fadnes H. O., Øian P., Maltau J. M. Transcapillary fluid dynamics during ovarian stimulation for in vitro fertilization. Am J Obstet Gynecol 1990; 162: 554–8
- Kjeldsen S. E., Westheim A., Aakesson I., Eide I., Leren P. Plasma adrenaline and noradrenaline during orthostasis in man: the importance of arterial sampling. Scand J Clin Lab Invest 1986; 46: 397–401
- Hoist N., Bertheussen K., Forsdahl F., Hakonsen M. B., Jul Hansen L., Nielsen H. I. Optimization and simplification of culture conditions in human in vitro fertilization (IVF) and pre-embryo replacement by serum-free media. J In Vitro Fert Embryo Transfer 1990; 7: 47–53
- Peuler J. D., Johnson G. A. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 1977; 21: 625–36
- Kjeldsen S. E., Flaaten B., Eide I., Helgeland A., Leren P. Evidence of increased catecholamine release in patients with longstanding, untreated essential hypertension. Scand J Clin Lab Invest 1982; 42: 217–23
- Kondo K., Okunp T., Eguchi T., Yasui T., Suzuki H., Nagahama S., Saruta T. Vascular action of high dose oestrogen in rats. Endocrinol Jap 1980; 27: 307–13
- Veille J. C., Morton M. J., Burry K., Nemeth M., Speroff L. Oestradiol and hemodynamics during ovulation induction. J Clin Endocrinol Metab 1986; 63: 721–4
- Izzo J. Cardiovascular hormonal effects of circulating noradrenaline. Hypertension 1983; 5: 787–9
- Kjeldsen S. E., Schork N. J., Leren P., Eide I. Arterial plasma noradrenaline correlated to blood pressure in middle-aged men with sustained essential hypertension. Am Heart J 1989; 118: 775–81
- Esler M., Jennings G., Komer P., Blombery P., Sacharias N., Leonard P. Measurements of total and organ-specific noradrenaline kinetics in humans. Am J Physiol 1984; 247: E21–8
- Rosenfeld C. R., Jackson M. Oestrogen-induced refractoriness to the pressor effects of infused angiotensin II. Am J Obstet Gynecol 1984; 148: 429–35
- Naden R. P., Rosenfeld C. R. Systemic and uterine responsiveness to angiotensin II and noradrenaline in oestrogen-treated nonpregnant sheep. Am J Obstet Gynecol 1985; 153: 417–25